: Characteristics of chronic hepatitis B and C patients with fibrosis F0-F1-F2 and F3-F4.
None (A0) 5 ( Clinical parameters are expressed as median and interquartile range (IQ), unless indicated differentially. Differences between chronic hepatitis B and C patients were evaluated with the Fisher exact (qualitative variables) and the Wilcoxon rank-sum test (continuous variables). 49. 5 (37.25-55.0) 50. 5 (38.25-56.0) Time between the initiation of treatment and the second serum, months (median, IQ) 12.5 (11.5-14) 12.0 (9) (10) (11) (12) (13) ALT, IU/L (median, IQ) 44. 5 (37-55.75) 28 (24-47.5) 83 (60-130) 30 (25-32) AST, IU/L (median, IQ) Clinical parameters are expressed as median and interquartile range (IQ), unless indicated differentially. Differences between patients with F0-F1-F2 and those with F3-F4 were evaluated with the Fisher exact (qualitative variables) and the Wilcoxon rank-sum test (continuous variables). Clinical parameters are expressed as median and interquartile range (IQ), unless indicated differentially. Differences between patients with F0-F1-F2 and those with F3-F4 were evaluated with the Fisher exact (qualitative variables) and the Wilcoxon rank-sum test (continuous variables). 2 (4.7-6.7) 4.5 (4.4-4.9) 5.3 (4.6-5.6 ) Total bilirubin, μmol/L (median, IQ) 16.5 (11.7-18.2) 18 (16.7-26.2) 13.5 (10.7-16) 12 (10.5-15.2) Albumin, g/L (median, IQ) 46. 2 (41.9-50.6) 42. 4 (41.3-45.1) 
